Your session is about to expire
← Back to Search
Behavioural Intervention
Experimental for Hemophilia
N/A
Waitlist Available
Led By Stan Kachnowski, PhD, MPA
Research Sponsored by Healthcare Innovation Technology Lab
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 128 days
Awards & highlights
Study Summary
The purpose of this study is to evaluate the utility and user experience of a smart phone app for people with medical conditions, used in conjunction with an ActiGraph wearable device and a connected scale.
Eligible Conditions
- Hemophilia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 128 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~128 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Device usability as assessed by the System Usability Scale (SUS)
Usage of the SureSource Engage application as assessed by ActiLife software
Trial Design
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
Multiple device intervention
SureSource Engage mobile application
ActiGraph Link
weight scale
Find a Location
Who is running the clinical trial?
BayerIndustry Sponsor
2,237 Previous Clinical Trials
25,326,958 Total Patients Enrolled
6 Trials studying Hemophilia
659 Patients Enrolled for Hemophilia
Healthcare Innovation Technology LabLead Sponsor
4 Previous Clinical Trials
202 Total Patients Enrolled
Stan Kachnowski, PhD, MPAPrincipal InvestigatorHealthcare Innovation Technology Lab
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger